Skip to main content

Hospital-Administered Opioid Antagonist Reimbursement (APA WF 24-04  & OK SPA 24-0005)

As directed by Senate Bill 712, Oklahoma Health Care Authority will seek federal and state approval to allow the Agency to separately reimburse for opioid antagonists provided to members in an emergency department with symptoms of an opioid overdose, opioid disorder, or any other adverse opioid event related to opioid use. 

Please view the circulation document here: APA WF #24-04

Please view the draft SPA pages here: OK SPA 24-0005

Feedback may be submitted via the comment box.

Circulation Date: 01/02/2024

Comment Due Date: 01/17/2024

Medical Advisory Committee (MAC) Meeting: 03/07/2024

Board Meeting: 03/20/2024

Submit a Comment

Couldn't verify captcha, Please refresh the page and try again.

After you submit your comment, you should be re-directed to a confirmation page. If you are not, please submit your comment through e-mail to federal.authorities@okhca.org.

Please note that all comments must be reviewed and approved prior to posting. Approved comments will be posted Monday through Friday between the hours of 7:30 a.m. – 4 p.m. Any comments received after 4 p.m. will be posted on the following business day.

Comments

No comments.

Last Modified on Jan 24, 2024
Back to top

Oklahoma Health Care Authority

4345 N Lincoln Blvd

Oklahoma City, OK 73105

Contact Us

The Oklahoma Health Care Authority collects the personally identifiable data submitted and received in regard to applications for services, renewals, appeals, provision of health care and processing of claims. This data is treated as confidential and is stored securely in accordance with applicable law and regulations. OHCA may share this personally identifiable data with its authorized business associates, government agencies with jurisdiction over the OHCA, or as otherwise required or permitted by applicable law.